FairValueLabs Valuation System Value Investment
IBM

International Business Machines Corporation (IBM) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Technology · Information Technology Services

$251.86 Fairly Valued -3.82 (-1.5%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
3.32
Altman Z-ScoreSafe Zone
$223.49
Fair ValueFairly Valued (-12.7%)
3.3
Moat RatingNarrow moat
TL;DR · Audit Summary

Is International Business Machines Corporation a safe investment right now?

International Business Machines Corporation's Altman Z-Score of 3.32 places it in the safe zone. Our fair value estimate is $223.49 (Fairly Valued). Moat rating: 3.3/5 stars.

Price Chart · IBM
Section 01 · Financial Health

Could International Business Machines Corporation go bankrupt? Altman Z-Score analysis

3.32

Z-Score of 3.32 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives IBM's Z-Score?

Altman Z-Score components for IBM
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA-0.01131.2-0.01
B · Retained Earnings / Total AssetsRE / TA1.02481.41.43
C · EBIT / Total AssetsEBIT / TA0.08073.30.27
D · Market Cap / Total LiabilitiesMCap / TL1.98380.61.19
E · Revenue / Total AssetsRev / TA0.44471.00.44

How has IBM's financial health changed over time?

3.0 Safe1.8 Distress0.01.02.03.04.02022202320242025
IBM Z-Score history
YearZ-ScoreZone
20223.51Safe
20233.52Safe
20243.48Safe
20253.32Safe

Source: Calculated from IBM's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is International Business Machines Corporation actually worth?

FVL Fair Value$223.49
vs
Market Price$251.86
Fairly Valued -12.7% Stock trades 12.7% above our estimated fair value of $223.49.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$11.64Proprietary blend of reported actuals + analyst consensus, weighted by α
Last Year EPS$11.17Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$12.3520 analysts consensus
Trailing P/E22.6xCurrent market pricing
Fair P/E (β discount)19.2xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)GrowingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $296.33 (20 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does International Business Machines Corporation have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.3/5.

What makes up IBM's moat score?

ROIC Stability

★★★☆☆

ROIC variability over the past decade. Score: 3/5.

Gross Margin Trend

★★★★☆

Gross margin trajectory over the past decade. Score: 4/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is IBM's return on invested capital?

0%-5%1%7%12%18%2022202320242025
IBM ROIC history
YearROICTrend
20223.2%
202313.0%Rising
20249.1%Declining
202513.1%Rising

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is International Business Machines Corporation's dividend safe?

B Dividend Safety Grade
Yield2.6%
Payout Ratio60.2%
Consecutive Years65
5Y Growth Rate-23.3%

Can International Business Machines Corporation afford its dividend?

Payout ratio is 60.2%. FCF covers the dividend 1.4x. 65 consecutive years of payments.

Section 05 · Financial Summary

International Business Machines Corporation's key financial metrics

IBM financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $67.5B $62.8B $60.5B Rising
Net Income $10.6B $6.0B $1.6B Rising
Free Cash Flow $11.5B $11.8B $8.5B Rising
Gross Margin 58.2% 56.6% 54.0% Rising
Section 06 · Lab Signals

Recent events that affect our IBM analysis

ANALYST

IBM analyst consensus: 57% bullish (12 of 21 analysts)

Lab Impact

2 Strong Buy, 10 Buy, 7 Hold, 1 Sell, 1 Strong Sell. Consensus target: $296.33 (17.7% upside). Compare with our independent Fair Value: $223.49.

EARNINGS

IBM beat EPS estimates by 5.5%

Lab Impact

Reported EPS: $1.91 vs estimate $1.81. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

DIVIDEND

IBM paid $1.6800/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 60.2%.

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

IBM beat EPS estimates by 5.3%

Lab Impact

Reported EPS: $4.52 vs estimate $4.29. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

IBM paid $1.6800/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 60.2%.

FILING

IBM filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

IBM beat EPS estimates by 8.3%

Lab Impact

Reported EPS: $2.65 vs estimate $2.45. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

IBM paid $1.6800/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 60.2%.

FILING

IBM filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

IBM beat EPS estimates by 5.5%

Lab Impact

Reported EPS: $2.80 vs estimate $2.65. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

IBM paid $1.6800/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 60.2%.

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

IBM beat EPS estimates by 4.0%

Lab Impact

Reported EPS: $1.12 vs estimate $1.08. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

DIVIDEND

IBM paid $1.6700/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 60.2%.

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

IBM beat EPS estimates by 3.8%

Lab Impact

Reported EPS: $3.92 vs estimate $3.78. Earnings strength supports our Fair Value of $223.49 (11.3% below current price).

FILING

IBM filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about International Business Machines Corporation

What is International Business Machines Corporation stock price today?

International Business Machines Corporation (IBM) stock price is $251.86 as of the latest market close, traded on the NYSE exchange.

What does International Business Machines Corporation do?

International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers hybrid cloud and AI platforms that allow clients to realize their digital and AI transformations across the applications, data, and environments in which they operate.

What is International Business Machines Corporation market cap?

International Business Machines Corporation has a market capitalization of $236.35B, classifying it as a mega-cap stock in the Technology sector.

What sector and industry is IBM in?

International Business Machines Corporation operates in the Technology sector, specifically within the Information Technology Services industry. It trades on the NYSE under the ticker symbol IBM.

Is IBM stock overvalued or undervalued?

Based on our valuation model, International Business Machines Corporation trades 12.7% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $223.49
  • Current Price: $251.86
  • Valuation Zone: Fairly Valued
What is IBM stock forecast and analyst target price?

Based on 20 Wall Street analysts, the consensus price target for International Business Machines Corporation is $296.33, implying upside of 17.7% from the current price.

  • Analyst High Target: $390.00
  • Analyst Low Target: $215.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is International Business Machines Corporation revenue and earnings growing?

Here are the analyst consensus growth estimates for International Business Machines Corporation:

  • Revenue growth (current year est.): 5.4%
  • EPS growth (current year est.): 6.6%
  • Revenue growth (next year est.): 4.6%
  • EPS growth (next year est.): 8.4%
What are International Business Machines Corporation's key financial metrics?
MetricLatestTrend
Revenue$67.5BRising
Net Income$10.6BRising
Free Cash Flow$11.5BRising
Gross Margin58.2%Rising
What is IBM's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 22.6x
  • Forward P/E (next 12 months est.): 18.8x
  • FairValueLabs Fair P/E: 19.2x
How volatile is IBM stock?

International Business Machines Corporation has a beta of 0.69, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does International Business Machines Corporation have?

International Business Machines Corporation's balance sheet shows:

  • Total Cash: $14.42B
  • Total Debt: $64.61B
  • Net Cash Position: $-50.19B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is International Business Machines Corporation's free cash flow?

International Business Machines Corporation generated $13.16B in trailing twelve-month free cash flow (from $13.19B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does International Business Machines Corporation pay a dividend, and is it safe?

Yes, International Business Machines Corporation pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 2.6%
  • Payout Ratio: 60.2%
  • Consecutive Years Paid: 65
  • 5-Year Dividend Growth: -23.3%
  • FairValueLabs Safety Grade: B
Is International Business Machines Corporation at risk of going bankrupt?

International Business Machines Corporation's Altman Z-Score is 3.32, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does International Business Machines Corporation have a durable competitive advantage?

International Business Machines Corporation scores 3.3/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 3/5
  • Gross Margin Trend: 4/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is IBM's return on equity (ROE)?

International Business Machines Corporation's return on equity is 35.2%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy IBM stock?

IBM shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol IBM
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is IBM a value stock or speculative?

FairValueLabs classifies International Business Machines Corporation as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of International Business Machines Corporation?

The current CEO of International Business Machines Corporation is Mr. Arvind Krishna.

What is IBM's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $11.13
  • Forward EPS (next 12 months est.): $13.38
  • Analyst consensus EPS (this year): $12.35
  • Analyst consensus EPS (next year): $13.38

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

IBM analysis methodology: How we calculate fair value, Z-Scores, and moat ratings